Cancer Health Treatment Update How Has COVID-19 Affected Cancer Care? Cancer patients not only are at increased risk for severe COVID-19, but they also face treatment interruptions due to the pandemic, according to a new AACR report. FDA Approves Second CAR-T Therapy for Multiple Myeloma 98% of people who received the customized immunotherapy responded to the one-time treatment. Gut Compounds Linked to Aggressive Prostate Cancer Study findings have implications for both diagnosis and prevention—and even for treatment. Healing the Immune System After Radiation and Chemotherapy New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy. Advertisement People From Marginalized Groups Report Frequent COVID-Related Discrimination COVID-19-related discrimination includes threats against or harassment of people perceived to have the coronavirus. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed President Biden Shines Spotlight on Military Burn Pits and Cancer People From Marginalized Groups Report Frequent COVID-Related Discrimination Musical Passion Reignited 6 Years After Bile Duct Cancer Diagnosis Study Identifies Potential Drug Target to Prevent Some Liver Cancers Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed President Biden Shines Spotlight on Military Burn Pits and Cancer People From Marginalized Groups Report Frequent COVID-Related Discrimination Musical Passion Reignited 6 Years After Bile Duct Cancer Diagnosis Study Identifies Potential Drug Target to Prevent Some Liver Cancers Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: